NON-SMALL CELL LUNG CARCINOMA

This study tested a targeted pill called capmatinib in 50 Indian adults with advanced non-small cell lung cancer that has a specific genetic change (MET exon 14 skipping mutation). The goal was to see how safe the drug is and how well it shrinks tumors. Participants could be newl…

This study tested a new immunotherapy drug, cemiplimab, against standard chemotherapy for people with advanced non-small cell lung cancer that has a specific marker (PD-L1). About 700 patients participated. The goal was to see if cemiplimab helps people live longer and keeps the …

This early-phase study tested a light-measuring system used during surgery to treat mesothelioma, non-small cell lung cancer, or other cancers that spread to the lining of the lungs. Nine participants received a light-activated drug called porfimer sodium, and doctors used the sy…

This study looked at whether adding metformin (a common diabetes medicine) to standard chemotherapy and radiation helps people with stage III non-small cell lung cancer live longer without their cancer growing. About 170 adults with this type of lung cancer took part. The goal wa…

This study looked at how well the drug lorlatinib works for people with advanced non-small cell lung cancer that has a specific gene change (ALK) and has stopped responding to earlier treatments. Researchers tracked 73 adults in Taiwan who took lorlatinib pills at home. The goal …

This study tested whether adding vibostolimab to pembrolizumab (Keytruda) helps people with advanced PD-L1 positive non-small cell lung cancer live longer or keep cancer from growing, compared to pembrolizumab alone. Over 1,200 participants received either the combination or the …

This study looked at whether giving the immunotherapy drug pembrolizumab before and after surgery is safe and feasible for people with early-stage non-small cell lung cancer. 35 participants received two doses before surgery and four doses after. The main goal was to see if surge…

This study watched 46 patients with a type of lung cancer that hadn't caused symptoms yet. Doctors chose to give radiation right away or wait and see. The goal was to learn how doctors make that choice and how patients felt over time. No new treatment was tested.

This study looked at whether a blood test that detects tumor DNA could help monitor lung cancer progression without needing a biopsy. Researchers tested 200 patients with non-small cell or small cell lung cancer. The goal was to see if this non-invasive method could track how the…